The SOLACE-AU Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.
Also called NCT01675596
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 199 participants
- Sponsor
- Registry
-
NCT01675596
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Australia
- Registry status
- Completed
Technical summary
Registry record NCT01675596. Allocation not applicable; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2016-02 (actual). Results posted on 2019-04-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The SOLACE-AU Clinical Trial
- Acronym
- SOLACE-AU
- Condition
- Severe, Symptomatic Aortic Stenosis
- Intervention (Device)
- TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
- Lead sponsor
- Edwards Lifesciences
- Collaborator
- Pacific Clinical Research Group
Record details
- Record id
cardio:ct-nct01675596- Content hash
ad0fde0cf6e9009b601eab867875f49e6283e16255eb099c020d02d185493c8e